Cargando…
Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why
It is well known that chemotherapy can cure only some cancers in advanced stage, mostly those with an intact p53 pathway. Hematological cancers such as lymphoma and certain forms of leukemia are paradigmatic examples of such scenario. Recent evidence indicates that the efficacy of many of the alkyla...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984324/ https://www.ncbi.nlm.nih.gov/pubmed/29855342 http://dx.doi.org/10.1186/s13045-018-0609-1 |